CLINICAL_TRIALS
trial_result
· 2017-09-19
Clinical Trial Update: Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil [Phase 3]
Summary
Phase 3 trial investigating idalopirdine added to donepezil in mild-to-moderate Alzheimer's disease has completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-09-19